We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+21.48%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$21.4B
AUM Growth
+$2.83B
(+15%)
Cap. Flow
+$1.67B
Cap. Flow
% of AUM
7.78%
Top 10 Holdings %
Top 10 Hldgs %
10.34%
Holding
1,926
New
598
Increased
490
Reduced
463
Closed
369
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vulcan Materials
VMC
|
+$180M |
| 2 |
Walmart Inc
WMT
|
+$154M |
| 3 |
McDonald's
MCD
|
+$143M |
| 4 |
Hartford Financial Services
HIG
|
+$143M |
| 5 |
Citigroup
C
|
+$136M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$153M |
| 2 |
Advance Auto Parts
AAP
|
+$131M |
| 3 |
Wells Fargo
WFC
|
+$130M |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$116M |
| 5 |
Abbott
ABT
|
+$103M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.48% |
| 2 | Consumer Discretionary | 12.21% |
| 3 | Healthcare | 8.51% |
| 4 | Technology | 7.64% |
| 5 | Communication Services | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Thermo Fisher Scientific
TMO
$220B
| $1.56M | 0.01% |
10,181
-152,193
| -94% | -$23.3M |
|
977
CALL
Teradata
TDC
$2.55B
| $1.56M | 0.01% |
50,000
-109,600
| -69% | -$3.31M |
|
|
ONCE
978
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.55M | 0.01% |
29,000
-42,600
| -59% | -$2.53M |
|
979
Phillips 66
PSX
$81.4B
| $1.54M | 0.01% |
19,506
+6,706
| +52% | +$540K |
|
980
NVIDIA
NVDA
$5.42T
| $1.54M | 0.01% |
+564,000
| New | +$1.5M |
|
981
BorgWarner
BWA
$13.9B
| $1.53M | 0.01% |
+41,724
| New | +$1.52M |
|
982
Zoetis
ZTS
$30.5B
| $1.52M | 0.01% |
28,500
-877,610
| -97% | -$47.4M |
|
983
Metallus
MTUS
$898M
| $1.52M | 0.01% |
+80,386
| New | +$1.43M |
|
|
KCG
984
DELISTED
KCG Holdings, Inc.
KCG
| $1.51M | 0.01% |
84,824
-156,848
| -65% | -$2.33M |
|
|
CIT
985
DELISTED
CIT Group Inc.
CIT
| $1.51M | 0.01% |
35,225
+16,725
| +90% | +$708K |
|
986
Patterson-UTI
PTEN
$3.76B
| $1.51M | 0.01% |
+62,248
| New | +$1.68M |
|
|
PX
987
DELISTED
Praxair Inc
PX
| $1.51M | 0.01% |
12,738
+10,578
| +490% | +$1.24M |
|
988
Boston Scientific
BSX
$71.5B
| $1.51M | 0.01% |
60,690
-14,989
| -20% | -$364K |
|
989
Elevance Health
ELV
$85.5B
| $1.51M | 0.01% |
9,121
-29,410
| -76% | -$4.68M |
|
990
Valley National Bancorp
VLY
$8.05B
| $1.49M | 0.01% |
125,899
-1,077,282
| -90% | -$12.9M |
|
991
PUT
Synaptics
SYNA
$4.15B
| $1.49M | 0.01% |
+30,000
| New | +$1.61M |
|
|
MRSH
992
Marsh
MRSH
$91.5B
| $1.48M | 0.01% |
19,961
-195,675
| -91% | -$14M |
|
993
PUT
Paychex
PAYX
$42.7B
| $1.47M | 0.01% |
+25,000
| New | +$1.52M |
|
994
Interface
TILE
$2.22B
| $1.47M | 0.01% |
77,300
-1,371,925
| -95% | -$25.4M |
|
995
Pitney Bowes
PBI
$2.39B
| $1.47M | 0.01% |
111,770
+98,430
| +738% | +$1.39M |
|
996
Sherwin-Williams
SHW
$89.8B
| $1.46M | 0.01% |
14,133
-577,392
| -98% | -$58.2M |
|
997
Reinsurance Group of America
RGA
$16.1B
| $1.46M | 0.01% |
11,466
+7,913
| +223% | +$1M |
|
998
CALL
Warner Bros
WBD
$67.1B
| $1.46M | 0.01% |
50,000
-50,000
| -50% | -$1.4M |
|
999
Twilio
TWLO
$36.6B
| $1.44M | 0.01% |
50,000
-10,000
| -17% | -$302K |
|
1000
CALL
Coherent
COHR
$74.2B
| $1.44M | 0.01% |
+40,000
| New | +$1.41M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q1 2017 Portfolio in Review
As of Q1 2017, Balyasny Asset Management held 1,926 positions worth $21.4B, up 15% from $18.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Balyasny Asset Management deployed $1.67B of net new capital in Q1 2017, opening 598 new positions and adding to 490 existing holdings. Its largest new stake was Citigroup: 2,292,111 shares worth $137M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Freeport-McMoran, an estimated $153M trimmed.
- Balyasny Asset Management's largest Q1 2017 buy was Citigroup: 2,292,111 shares worth $137M.
- Balyasny Asset Management added most to Vulcan Materials in Q1 2017, an estimated $180M increase.
- Balyasny Asset Management's biggest Q1 2017 reduction was Freeport-McMoran, cutting an estimated $153M.
- Balyasny Asset Management fully exited Coterra Energy in Q1 2017, selling an estimated $116M.
- Balyasny Asset Management's ten largest holdings make up 10% of its $21.4B portfolio in Q1 2017.
- Balyasny Asset Management opened 598 new positions and closed 369 in Q1 2017.
- Balyasny Asset Management's portfolio value rose 15% quarter-over-quarter to $21.4B.
Based on Balyasny Asset Management's 13F filing for Q1 2017, filed 15 May 2017.